The Chemotherapy At Home Services Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for chemotherapy at home services has seen a rapid expansion in the past few years. The market is expected to increase from $1.75 billion in 2024 to $1.95 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 11.5%.
The Chemotherapy At Home Services market is projected to reach a size of $2.97 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.1%.
Download Your Free Sample of the 2025 Chemotherapy At Home Services Market Report and Uncover Key Trends Now!The drivers in the chemotherapy at home services market are:
• Rising cancer incidence rates globally
• Increasing patient preference for home-based care
• Challenges regarding hospital capacity constraints
• Enhancement of home healthcare infrastructure and support from government policies
The chemotherapy at home services market covered in this report is segmented –
1) By Product: Chemotherapy Drugs, Chemotherapy Infusion Pumps
2) By Administration: Oral, Intravenous
3) By Application: Breast Cancer, Blood Cancer, Ovarian Cancer, Colorectal Cancer
The trends in the chemotherapy at home services market are:
• Integration of AI and machine learning is a major upcoming trend.
• Personalized medicine approaches are increasingly shaping the future.
• The market is significantly influenced by the adoption of wearable health technology.
• There is a growing trend towards specialty home infusion services and collaborative healthcare models.
The major players in the chemotherapy at home services market are:
• CVS Health Corporation
• Optum Inc
North America was the largest region in the chemotherapy at-home services market in 2023